Case Study

How Clinovo’s Dedicated SSU Team Enabled a Sponsor’s Global Phase 3 Launch Ahead of Schedule

A biopharmaceutical sponsor specializing in rare diseases, oncology, and neurology faced a pivotal moment: three early-phase studies were transitioning into in-human trials, and a first-of-its-kind global Phase 3 was on the horizon.

But with limited headcount approvals, rising operational pressure, and no margin for error, internal teams were stretched thin.

Rather than disrupt ongoing study execution or risk costly startup delays, the sponsor partnered with Clinovo to implement a dedicated Study Startup (SSU) team— injecting specialized expertise, preserving internal bandwidth, and accelerating timelines.

Ready to Scale Your Operations with Discipline and Confidence?

KEY RESULTS

Measurable Impact in Weeks and Months, Not Years

Clinovo’s targeted SSU deployment created immediate, measurable results:

8 SSU experts embedded, from Clinical Project Manager through Associate Director—each selected for global regulatory expertise and sponsor alignment across APAC, LATAM, EU, and US¹

Zero attrition over 24 months, preserving continuity, institutional knowledge, and execution consistency²

All early-phase studies launched on time and on budget, despite constrained headcount and aggressive timelines¹

Global Phase 3 initiated ahead of schedule,with no regulatory queries returned—reflecting flawless documentation, proactive authority engagement, and seamless site activation¹

STRATEGIC IMPACT

Lasting Operational Stability

Clinovo’s SSU team delivered more than accelerated startup—it created lasting operational stability and competitive advantage.

Operational discipline investors expect

On-time launches, zero disruption³

Workforce stability that protects timelines

0% attrition avoided costly turnover²

Therapeutic and regulatory alignment

Accelerated approvals, smoother site activation¹

Scalable oversight without CRO disruption

Sponsor control without the burden of permanent headcount²

Ready to Optimize Your Study Startup?

Download the full case study to learn how Clinovo’s sponsor-aligned SSU model can accelerate your timelines and protect your pipeline—without compromise.

References: 1. Clinovo. Validated Performance Metrics Across Client Engagements. Internal data, 2023–2025. | 2. Clinovo. Workforce Retention Metrics. Internal data, 2023–2025 | 3. Clinovo. AI Workforce Optimizer Validated Performance. Internal data, 2023–2025